Amendment No. 2 to Separation Agreement between Abeona Therapeutics, Inc. and Steven Rouhandeh

Summary

Abeona Therapeutics, Inc. and Steven Rouhandeh have agreed to amend their original Separation Agreement. This amendment changes the effective date of Mr. Rouhandeh's separation from the company to be either June 30, 2020, or the date a new Executive Chairman is appointed, whichever comes first. All other terms of the original agreement remain unchanged.

EX-10.4 5 ex10-4.htm

Exhibit 10.4

Amendment No. 2

Separation Agreement

March 31, 2020

Reference is hereby made to that certain Separation Agreement between Abeona Therapeutics, Inc. (the “Company”) and Steven Rouhandeh (the “Executive”), dated January 2, 2020 (the “Separation Agreement”).

WHEREAS, the Company and the Executive desire to amend the Separation Agreement, as amended

NOW THEREFORE, the parties hereby agree as follows:

1. The first sentence of Section 1 is hereby amended with the following:

“Your effective date of separation from the Company will be the earlier of (a) June 30, 2020 or (b) the date that the Board appoints a new Executive Chairman of the Company (the “Separation Date”).

ACCEPTED AND AGREED:

	Abeona Therapeutics, Inc.

		/s/ Mark J. Alvino
	By:	Mark J. Alvino
	Title:	Chair Comp. Comm

		/s/ Steven H. Rouhandeh
		Steven H. Rouhandeh